OMC
LABU icon

Old Mission Capital’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Old Mission Capital’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,156
Closed -$202K – 1183
2025
Q3 		$202K Sell
2,156
-4,719
-69% -$333K ﹤0.01% 1003
2025
Q2 		$391K Buy
+6,875
New +$365K 0.01% 806
2023
Q2 		– Sell
-1,195
Closed -$117K – 1456
2023
Q1 		$117K Buy
+1,195
New +$162K ﹤0.01% 1246
2021
Q2 		– Sell
-2,071
Closed -$3.27M – 1149
2021
Q1 		$3.27M Buy
+2,071
New +$4.85M 0.18% 145

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Old Mission Capital's LABU Position: Q4 2025 in Review

Old Mission Capital sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2025, closing a stake of 2,156 shares — an estimated $202K sold.

Old Mission Capital first reported a position in LABU in Q1 2021 and held it in 4 quarters. The position peaked at $3.27M in Q1 2021. 40 funds tracked by Wall St. Rank hold LABU as of Q4 2025.

  • Old Mission Capital reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2025 after selling out during the quarter.
  • Old Mission Capital sold 2,156 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2025, an estimated $202K.
  • Old Mission Capital first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2021 and held it in 4 quarters.
  • Old Mission Capital's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3.27M in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2025.

Based on Old Mission Capital's 13F filing for Q4 2025, filed 17 Feb 2026.